Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy and safety of Runzao zhiyang capsule in treating chronic eczema.


Clinical Trial Description

Polygoni multiflori Preparata, dried rehmannia root, mulberry leaf, sophora flavescens, Honghuoma, for skin itching, acne, constipation due to blood vacuity and wind-dryness, also used in clinical treatment of eczema.

The purpose of this study is to evaluate the efficacy and safety of Runzao zhiyang capsule in treating chronic eczema. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02601222
Study type Interventional
Source Guizhou Tongjitang Pharmaceutical Co.,Ltd
Contact Gu heng, M.D.
Phone +86-25-85478045
Status Recruiting
Phase Phase 4
Start date March 2016
Completion date February 2017

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03485560 - Revitalization of Damaged Skin Due to Chronic Skin Diseases Early Phase 1
Completed NCT04016025 - A Clinical Study of Adherence to Methylprednisolone Aceponate in Different Carriers Phase 4